HBI0101 (NXC-201) CAR-T Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HBI0101 (NXC-201) CAR-T Therapy, covering 2025-05-14 to 2025-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis [Phase 2]